Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-Driven Integration of Muscle Mass and Muscle Function: A Novel Approach to Sarcopenia Risk Assessment and Intervention

NCT07426159 is registered in ClinicalTrials.gov with Tel Aviv University as lead sponsor.

NCT NCT07426159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07426159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI-Driven Integration of Muscle Mass and Muscle Function: A Novel Approach to Sarcopenia Risk Assessment and Intervention
Lead sponsor
Tel Aviv University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 1, 2026
Completion date
December 31, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related muscle loss, sarcopenia